The shuffling of psychedelics companies into and out of success as shown in their respective quarterly earnings and annual reports over the last few weeks offers a glimpse into what it takes to survive and thrive in the industry. The strategic acquisition, development of novel therapeutics, and building awareness and collaborations are the names of […]